Innocare (09969) announced that on April 24, 2026, the company granted 15.3892 million restricted share units under the 2023 Equity Incentive Plan to three grantees. These units represent approximately 0.87% of the company's total issued shares as of the announcement date, excluding treasury shares. The grant of restricted share units to the relevant executive director is conditional upon and subject to approval by shareholders at the upcoming Annual General Meeting.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments